66 results
Page 2 of 4
8-K
EX-2.1
9afc 2cdn7a74m5of5
29 Mar 21
Tempest and Millendo Announce Proposed Merger Agreement
7:29am
425
EX-2.1
2qia3if 0xgxwm8xg
29 Mar 21
Business combination disclosure
7:27am
8-K
EX-10.1
7ds87js x1wtjbtw
17 Apr 19
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
bc36uif0a0pxqtlt4b
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
DEFM14A
p9o55aoj7sk 9o
6 Nov 18
Proxy related to merger
12:00am
424B3
qagoiqjq9a3im2mytro
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
x0qjnil6dmtc 34o
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-2.1
1kxlayt
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
l35573c wcncgjavpy
9 Aug 18
Business combination disclosure
5:17pm